(19)
(11) EP 3 773 508 A1

(12)

(43) Date of publication:
17.02.2021 Bulletin 2021/07

(21) Application number: 19713738.3

(22) Date of filing: 21.03.2019
(51) International Patent Classification (IPC): 
A61K 9/16(2006.01)
A61K 9/20(2006.01)
A61K 31/496(2006.01)
(86) International application number:
PCT/EP2019/057016
(87) International publication number:
WO 2019/185432 (03.10.2019 Gazette 2019/40)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 26.03.2018 EP 18461541

(71) Applicant: Adamed Pharma S.A.
05-152 Czosnow (PL)

(72) Inventors:
  • GARBERA, Kamil
    59-220 Legnica (PL)
  • WOS-LATOSI, Katarzyna
    05-092 Lomianki (PL)

(74) Representative: Sulikowski, Daniel 
Admarka sp. z o.o. Pienków, ul. Mariana Adamkiewicza 6
05-152 Czosnów
05-152 Czosnów (PL)

   


(54) PHARMACEUTICAL COMPOSITION COMPRISING BREXPIPRAZOLE